Report #2842686

Overview

Sex

Female

Age

Age unknown

State

IN

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

Incomplete scheme dose; This non-serious case was reported by a physician via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received DTPa (Infanrix) for prophylaxis. Previously administered products included Infanrix (received 1st dose of vaccine on an unknown date), Infanrix (received 2nd dose of vaccine on an unknown date) and Infanrix (received 3rd dose of vaccine on 23rd June 2023). On an unknown date, the patient did not receive the 4th dose of Infanrix. On an unknown date, an unknown time after receiving Infanrix, the patient experienced incomplete course of vaccination (Verbatim: Incomplete scheme dose). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 20-MAY-2025 On 20th May 2025, an physician requested information regarding a 7 year old patient and the possibility of administering a Boostrix booster dose for the DTaP vaccine scheme. The physician stated that the patient was from another country and had received only three doses of DTaP. Since the patient had not completed the full DTaP vaccination schedule, local authorities required a Boostrix booster dose. The physician reported that the DTaP vaccines the patient had received were Infanrix, with the last dose administered on 23rd June 2023. During the call, the healthcare professional noted that the patient had received the three doses as an infant but did not provide specific dates, only mentioning that the last dose was given on 23rd June 2023. The MD consented to follow up. Till the time of reporting, the patient did not receive 4th dose of Infanrix, which led to incomplete course of vaccination.